E Acevedo Selected Research

Arthrotec

1/2001

Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Acevedo Research Topics

Disease

2	Osteoarthritis 01/2001 - 02/2000
1	Rheumatoid Arthritis 08/2001
1	Necrosis 08/2001
1	Abdominal Pain (Pain, Abdominal) 01/2001
1	Diarrhea 01/2001
1	Nausea 01/2001
1	Dyspepsia (Indigestion) 01/2001
1	Heartburn (Pyrosis) 01/2001
1	Vomiting 01/2001
1	Peptic Ulcer (Peptic Ulcers) 02/2000
1	Ulcer 02/2000

Drug/Important Bio-Agent (IBA)

2	rofecoxib (Vioxx)FDA Link 01/2001 - 02/2000
1	HLA-DQA1 antigen (HLA DQA1)IBA 08/2001
1	HLA-DQB1 antigen (HLA DQB1)IBA 08/2001
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2001
1	Misoprostol (Cytotec)FDA LinkGeneric 01/2001
1	AcidsIBA 01/2001
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2001
1	Arthrotec FDA Link 01/2001
1	Diclofenac (SR 38)FDA LinkGeneric 01/2001
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2000
1	Ibuprofen (Motrin)FDA LinkGeneric 02/2000
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2000